Please use this identifier to cite or link to this item:
|標題:||Essential role of PKC delta in histone deacetylase inhibitor-induced Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells||作者:||Lee, H.H.
|關鍵字:||protein-kinase-c;sarcoma-associated herpesvirus;lytic cycle;sp1;sites;activation mechanisms;signaling pathway;expression;induction;promoter;gene||Project:||Journal of General Virology||期刊/報告no：:||Journal of General Virology, Volume 89, Page(s) 878-883.||摘要:||
Histone deactylase inhibitors (HDACi) are common chemotherapeutic agents that stimulate Epstein-Barr virus (EBV) reactivation; the detailed mechanism remains obscure. In this study, it is demonstrated that PKC delta is required for induction of the EBV lytic cycle by HDACi. Inhibition of PKC delta abrogates HDACi-mediated transcriptional activation of the Zta promoter and downstream lytic gene expression. Nuclear translocation of PKC delta is observed following HDACi stimulation and its overexpression leads to progression of the EBV lytic cycle. Our study suggests that PKC delta is a crucial mediator of EBV reactivation and provides a novel insight to study the regulation of the EBV lytic cycle.
|Appears in Collections:||生命科學院|
Show full item record
TAIR Related Article
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.